Avalo Therapeutics, Inc. vs Bone Biologics Corp — Valuation Comparison 2026
Access all valuation models for AVTX vs BBLG — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.
Access Full Analysis — From $27/mo →AVTX scores higher with a 4.7/10 quality rating vs BBLG's 3.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.
Comparing Avalo Therapeutics, Inc. (AVTX) and Bone Biologics Corp (BBLG) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.
AVTX currently trades at $16.13 with a QOC of 4.7/10, while BBLG trades at $1.30 with a QOC of 3.7/10.
Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).